Phillip G. Febbo
Chief Scientific & Med Officer at Veracyte · 10 reported transactions in 1 company · latest trade Sep 4, 2026
Their trades
Sold | Sep 4, 2026 | Sep 4, 2026 close $42.53 → Oct 29, 2026 close $52.17. S&P 500 −0.1% over the same days. | ||
Sold | Sep 4, 2026 | Sep 4, 2026 close $42.53 → Oct 29, 2026 close $52.17. S&P 500 −0.1% over the same days. | ||
Sold | Oct 6, 2025 | Oct 6, 2025 close $36.04 → Oct 29, 2026 close $52.17. S&P 500 +14.6% over the same days. |
SoldVeracyte
$118.1K
Sep 4, 2026 close $42.53 → Oct 29, 2026 close $52.17. S&P 500 −0.1% over the same days.
SoldVeracyte
$446.3K
Sep 4, 2026 close $42.53 → Oct 29, 2026 close $52.17. S&P 500 −0.1% over the same days.
SoldVeracyte
$300.7K
Oct 6, 2025 close $36.04 → Oct 29, 2026 close $52.17. S&P 500 +14.6% over the same days.